×
For best experience we recommend to activate Javascript in your browser.
EIF1AY antibody (AA 31-120)
The Mouse Monoclonal anti-EIF1AY antibody (Clone 2B8) (ABIN522522) specifically detects EIF1AY in ELISA, WB and IF.
The antibody is reactive with Human samples.
Catalog No. ABIN522522
$520.15
Plus shipping costs $50.00
Delivery in 11 to 14 Business Days
Quick Overview for EIF1AY antibody (AA 31-120) (ABIN522522)
Target
See all EIF1AY Antibodies
EIF1AY
(Eukaryotic Translation Initiation Factor 1A, Y-Linked (EIF1AY))
Reactivity
All reactivities for EIF1AY antibodies
Human
Host
All hosts for EIF1AY antibodies
Mouse
Clonality
All clonalities for EIF1AY antibodies
Monoclonal
Conjugate
All conjugates for EIF1AY antibodies
This EIF1AY antibody is un-conjugated
Application
All applications for EIF1AY antibodies
ELISA, Western Blotting (WB), Immunofluorescence (IF)
Clone
2B8
Product Details anti-EIF1AY Antibody
(hide)
Binding Specificity
All epitopes for EIF1AY antibodies
AA 31-120
Purpose
Mouse monoclonal antibody raised against a partial recombinant EIF1AY.
Sequence
DGQEYAQVIK MLGNGRLEAM CFDGVKRLCH IRGKLRKKVW INTSDIILVG LRDYQDNKAD VILKYNADEA RSLKAYGELP EHAKINETDT
Cross-Reactivity
Human
Characteristics
Antibody Reactive Against Recombinant Protein.
Immunogen
EIF1AY (NP_004672, 31 a.a. ~ 120 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Isotype
IgG2a
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Buffer
In 1x PBS, pH 7.4
Handling Advice
Aliquot to avoid repeated freezing and thawing.
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Target Details for EIF1AY
(hide)
Target
EIF1AY
(Eukaryotic Translation Initiation Factor 1A, Y-Linked (EIF1AY))
Alternative Name
EIF1AY
Background
Full Gene Name: eukaryotic translation initiation factor 1A, Y-linked Synonyms:
Gene ID
9086
NCBI Accession
NM_004681
Recently viewed
(hide)
Chat with us , powered by LiveChat